Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

AUTOIMMUNE RETINOPATHY IN A PATIENT WITH A MISSENSE MUTATION IN PITPNM3.

Bakhoum MF, Sengillo JD, Cui X, Tsang SH.

Retin Cases Brief Rep. 2017 Nov 22. doi: 10.1097/ICB.0000000000000673. [Epub ahead of print]

PMID:
29176531
2.

Autoimmune retinopathy associated with systemic lupus erythematosus: A diagnostic dilemma.

Wuthisiri W, Lai YH, Capasso J, Blidner M, Salz D, Kruger E, Levin AV.

Taiwan J Ophthalmol. 2017 Jul-Sep;7(3):172-176. doi: 10.4103/tjo.tjo_40_17.

3.

Outcomes in Autoimmune Retinopathy Patients Treated With Rituximab.

Sheemar A, Takkar B, Temkar S, Gaur N.

Am J Ophthalmol. 2017 Nov;183:166. doi: 10.1016/j.ajo.2017.09.013. Epub 2017 Sep 21. No abstract available.

PMID:
28941647
4.

Presumed autoimmune retinopathy following chickenpox; a case report.

Prime Z, Sims J, Danesh-Meyer H.

Int Ophthalmol. 2017 Aug 20. doi: 10.1007/s10792-017-0687-z. [Epub ahead of print]

PMID:
28825165
5.

B Cell Anomalies in Autoimmune Retinopathy (AIR).

Stansky E, Biancotto A, Dagur PK, Gangaputra S, Chaigne-Delalande B, Nussenblatt RB, Sen HN, McCoy JP Jr.

Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3600-3607. doi: 10.1167/iovs.17-21704.

6.

Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy.

Boudreault K, Justus S, Sengillo JD, Schuerch K, Lee W, Cabral T, Tsang SH.

Orphanet J Rare Dis. 2017 Jul 15;12(1):129. doi: 10.1186/s13023-017-0680-7.

7.

Rituximab for the Treatment of Autoimmune Retinopathy.

Forooghian F, MacDonald IM.

Am J Ophthalmol. 2017 Aug;180:xv-xvi. doi: 10.1016/j.ajo.2017.06.006. Epub 2017 Jun 27. No abstract available.

PMID:
28662767
8.

Antiretinal antibody- proven autoimmune retinopathy.

Abraham S, Sudharshan S, Bhende M, Ganesh SK, Gopal S.

Indian J Ophthalmol. 2017 May;65(5):416-420. doi: 10.4103/ijo.IJO_838_16.

9.

Impact of Autoantibodies against Glycolytic Enzymes on Pathogenicity of Autoimmune Retinopathy and Other Autoimmune Disorders.

Adamus G.

Front Immunol. 2017 Apr 28;8:505. doi: 10.3389/fimmu.2017.00505. eCollection 2017. Review.

10.

Outcomes in Autoimmune Retinopathy Patients Treated With Rituximab.

Davoudi S, Ebrahimiadib N, Yasa C, Sevgi DD, Roohipoor R, Papavasilieou E, Comander J, Sobrin L.

Am J Ophthalmol. 2017 Aug;180:124-132. doi: 10.1016/j.ajo.2017.04.019. Epub 2017 May 5.

PMID:
28483493
11.

Autoimmune retinopathy: A case report from India.

Ganesh SK, Ahmed AS.

Oman J Ophthalmol. 2017 Jan-Apr;10(1):40-43. doi: 10.4103/ojo.OJO_132_2014.

12.

Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy.

Maleki A, Lamba N, Ma L, Lee S, Schmidt A, Foster CS.

Clin Ophthalmol. 2017 Feb 17;11:377-385. doi: 10.2147/OPTH.S120162. eCollection 2017.

13.

EFFECT OF PLASMAPHERESIS AND PASSAGE OF ANTI-RETINAL ANTIBODIES THROUGH THE PLACENTA IN A CASE OF NON-PARANEOPLASTIC AUTOIMMUNE RETINOPATHY.

Sierpina DI, Skale DM, Fan JT.

Retin Cases Brief Rep. 2017 Winter;11 Suppl 1:S34-S37. doi: 10.1097/ICB.0000000000000395.

PMID:
28009774
14.

Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy.

Ten Berge JC, van Rosmalen J, Vermeer J, Hellström C, Lindskog C, Nilsson P, Qundos U, Rothova A, Schreurs MW.

PLoS One. 2016 Dec 8;11(12):e0167909. doi: 10.1371/journal.pone.0167909. eCollection 2016.

15.

Phage Immunoprecipitation Sequencing of Autoantigens in Autoimmune Retinopathy.

Davoudi S, Ahmadi T, Papavasilieou E, Leskov I, Sobrin L.

Ocul Immunol Inflamm. 2016 Oct 11:1-8. doi: 10.1080/09273948.2016.1232738. [Epub ahead of print]

PMID:
27726466
16.

Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy Using a Modified Delphi Approach.

Forooghian F.

Am J Ophthalmol. 2016 Oct;170:241-242. doi: 10.1016/j.ajo.2016.06.046. Epub 2016 Aug 17. No abstract available.

PMID:
27544042
17.

Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy Using a Modified Delphi Approach.

Fox AR, Gordon LK, Heckenlively JR, Davis JL, Goldstein DA, Lowder CY, Nussenblatt RB, Butler NJ, Dalal M, Jayasundera T, Smith WM, Lee RW, Adamus G, Chan CC, Hooks JJ, Morgans CW, Detrick B, Sen HN.

Am J Ophthalmol. 2016 Aug;168:183-190. doi: 10.1016/j.ajo.2016.05.013. Epub 2016 May 20.

18.

Unique epitopes for carbonic anhydrase II autoantibodies related to autoimmune retinopathy and cancer-associated retinopathy.

Adamus G, Yang S, Weleber RG.

Exp Eye Res. 2016 Jun;147:161-8. doi: 10.1016/j.exer.2016.05.012. Epub 2016 May 13.

PMID:
27185162
19.

GCAP1, Rab6, and HSP27: Novel Autoantibody Targets in Cancer-Associated Retinopathy and Autoimmune Retinopathy.

Yang S, Dizhoor A, Wilson DJ, Adamus G.

Transl Vis Sci Technol. 2016 May 2;5(3):1. eCollection 2016 May.

20.

Choroidal Thickness and En Face Optical Coherence Tomography Imaging in Autoimmune Retinopathy.

Polascik BA, Grewal DS, Jiramongkolchai K, Fekrat S.

Ophthalmic Surg Lasers Imaging Retina. 2016 Apr 1;47(4):362-5. doi: 10.3928/23258160-20160324-10.

PMID:
27065377

Supplemental Content

Loading ...
Support Center